Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

The ABHRS has outlined its goals for the next year.

Baricitinib may not always prevent relapse in alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The summit aimed to speed up finding treatments for alopecia areata.

Recognizing rare hair loss patterns in young females can improve understanding and treatment.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The AI model DIET-AI effectively diagnoses skin diseases as well as doctors.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Baricitinib is effective and safe for treating severe alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Alopecia areata in infants may be more common than previously thought.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The same gene mutation can cause different symptoms in family members.